1. Home
  2. FOLD vs BHF Comparison

FOLD vs BHF Comparison

Compare FOLD & BHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • BHF
  • Stock Information
  • Founded
  • FOLD 2002
  • BHF 2016
  • Country
  • FOLD United States
  • BHF United States
  • Employees
  • FOLD N/A
  • BHF N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • BHF Life Insurance
  • Sector
  • FOLD Health Care
  • BHF Finance
  • Exchange
  • FOLD Nasdaq
  • BHF Nasdaq
  • Market Cap
  • FOLD 2.8B
  • BHF 2.8B
  • IPO Year
  • FOLD 2007
  • BHF N/A
  • Fundamental
  • Price
  • FOLD $9.58
  • BHF $50.69
  • Analyst Decision
  • FOLD Strong Buy
  • BHF Hold
  • Analyst Count
  • FOLD 8
  • BHF 8
  • Target Price
  • FOLD $17.00
  • BHF $51.29
  • AVG Volume (30 Days)
  • FOLD 2.1M
  • BHF 290.8K
  • Earning Date
  • FOLD 02-26-2025
  • BHF 02-11-2025
  • Dividend Yield
  • FOLD N/A
  • BHF N/A
  • EPS Growth
  • FOLD N/A
  • BHF N/A
  • EPS
  • FOLD N/A
  • BHF N/A
  • Revenue
  • FOLD $493,671,000.00
  • BHF $4,860,000,000.00
  • Revenue This Year
  • FOLD $34.33
  • BHF N/A
  • Revenue Next Year
  • FOLD $21.70
  • BHF $4.82
  • P/E Ratio
  • FOLD N/A
  • BHF N/A
  • Revenue Growth
  • FOLD 32.58
  • BHF 91.79
  • 52 Week Low
  • FOLD $8.79
  • BHF $40.00
  • 52 Week High
  • FOLD $14.03
  • BHF $54.73
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 50.06
  • BHF 59.74
  • Support Level
  • FOLD $8.79
  • BHF $45.42
  • Resistance Level
  • FOLD $9.63
  • BHF $51.61
  • Average True Range (ATR)
  • FOLD 0.29
  • BHF 1.06
  • MACD
  • FOLD 0.05
  • BHF 0.48
  • Stochastic Oscillator
  • FOLD 90.48
  • BHF 87.24

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About BHF Brighthouse Financial Inc.

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, and Run-off. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.

Share on Social Networks: